Global Pharmaceutical Market Evolution: From Blockbuster Drugs to Biologics and Biosimilars – A Comprehensive Review

doi:https://doi.org/10.61336/JEEH/26-2-24

Journal of European Economic History journal thumbnail

Volume:7, Issue :2

Downloads

Download PDF xml

Download XML

Citations

60 Views

28 Downloads

Share this article

Useful Links

Frequently Asked Questions (FAQs)

Journal of European Economic History

2026, Volume:7, Issue :2 : 278-299 doi: https://doi.org/10.61336/JEEH/26-2-24

Research Article

Global Pharmaceutical Market Evolution: From Blockbuster Drugs to Biologics and Biosimilars – A Comprehensive Review

Mohit Kumar

Neelam Painuly

Abhishek Agrawal

Dr. Ashutosh Pathak

⁴

Pratibha Malik

⁵

Vishvendra Raj Malik

⁶

Akash Verma

⁷

Assistant Professor, Teerthanker Mahaveer College of Pharmacy, Teerthanker Mahaveer University, Moradabad-244001, U.P

Associate Professor, School of Pharmacy & Research, Dev Bhoomi Uttarakhand University, Naugaon, Dehradun, India

Associate Professor, IITM COLLEGE OF PHARMACY, Murthal, Sonipat;

⁴

Assistant Professor, Department of Pharmacy Practice, Teerthanker Mahaveer College of Pharmacy, Teerthanker Mahaveer University, Moradabad UP

⁵

Assistant Professor, Department of law and legal studies, Teerthanker Mahaveer College of law and legal studies, Teerthanker Mahaveer University, Moradabad UP, India

⁶

Assistant Professor, college of Law I is IIMT university Meerut;

⁷

Assistant Professor, Teerthanker Mahaveer College of Pharmacy, Teerthanker Mahaveer University, Moradabad-244001, U.P.

DOI : https://doi.org/10.61336/JEEH/26-2-24

Abstract

The global pharmaceutical industry has undergone a paradigm shift from the dominance of blockbuster small-molecule drugs to biologics and biosimilars. This transformation is driven by patent expirations, escalating research and development (R&D) costs, advancements in biotechnology, and the increasing burden of chronic diseases. Biologics now constitute a substantial portion of pharmaceutical expenditure, while biosimilars are emerging as cost-effective alternatives that enhance accessibility and sustainability of healthcare systems. This review critically evaluates the historical evolution, economic dynamics, regulatory frameworks, and future prospects of biologics and biosimilars, with a special emphasis on the Indian pharmaceutical landscape. Recent market data (2023–2025) highlight rapid growth in the biosimilars sector, with global expansion supported by regulatory harmonization and technological advancements.

Keywords

Biologics

Biosimilars

Pharmaceutical Industry

Patent Expiry

Biotechnology

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.

J Euro Eco His open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.

Recommended Articles

Research Article Open Access

Urban Living Labs in India’s Smart Cities: Public Awareness, Participation Willingness and Sustainability Perceptions

Ananya Bhardwaj ,

Shilpi Gupta

2026, Volume:7, Issue :2 : 491-498

DOI: https://doi.org/10.61336/JEEH/26-2-38

Download PDF

Research Article Open Access

The Economics of Apothecaries: Guilds, Pricing, and Consumer Access

Anurag verma ,

Pragati jain ,

Ashish Kumar Gupta

2026, Volume:7, Issue :2 : 375-399

DOI: https://doi.org/10.61336/JEEH/26-2-29

Download PDF

Research Article Open Access

An Influence of Regional/Local Celebrity Endorsement versus National Celebrity Endorsement on FMCG Consumer Buying Behaviour: A Study of Gen Z Consumers in Rajkot City

Vivek Vijayprakash Sondarva ,

Dr. Mahipal B. Ram

2026, Volume:7, Issue :2 : 441-447

DOI: https://doi.org/10.61336/JEEH/26-2-33

Download PDF

Research Article Open Access

Impact Analysis Of Income Tax Reforms On Revenue Generation And Taxpayer Behavior In India

Kinjal Agrawal ,

Dr. Dinesh Chandra Gupta ,

Prof. (Dr.) Dharmendra Mehta

2026, Volume:7, Issue :2 : 400-409

DOI: https://doi.org/10.61336/JEEH/26-2-30

Download PDF